What makes BPC-157 distinctive among research peptides is a combination of three properties rarely found together: it has no sequence homology to any other known peptide, it is completely stable in human gastric acid for at least 24 hours (unlike most growth factors and peptide analogues, which are rapidly degraded), and it remains active across an exceptionally broad effective dose range from nanogram to microgram per kilogram bodyweight in pre-clinical models without any known toxic dose having been established in animal studies to date
You have chosen to eat healthier and avoid animal products, but you dont seem to be feeling better or shedding excess weight
Thymosin Beta-4 has been studied in Phase II clinical trials for corneal wound healing, where it showed a 59% reduction in corneal staining compared to placebo
If this happens you won't be able to reconstitute correctly and the dosage will be stronger than you should take
Our peptide sciences research guide provides a broader overview of how these compounds are categorized and studied.
This compound is not approved for diagnostic, therapeutic, veterinary, or personal use
